Boston Scientific Corp (NYSE:BSX)

44.67
Delayed Data
As of Dec 12
 +0.85 / +1.94%
Today’s Change
31.56
Today|||52-Week Range
44.85
+26.40%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$61.5B

Company Description

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Cardiovascular, Rhythm Management, and MedSurg. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease, and other cardiovascular disorders including structural heart conditions. The Rhythm Management segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal, and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Contact Information

Boston Scientific Corp.
300 Boston Scientific Way
Marlborough Massachusetts 01752-1234
P:(508) 683-4000
Investor Relations:
(508) 683-5565

Employees

Shareholders

Mutual fund holders57.14%
Other institutional37.24%
Individual stakeholders1.45%

Top Executives

There are no executives to display.